Cargando…

Risk factors associated with the occurrence of adverse events in plateletpheresis donation

OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Maria Helena, da Silva, Karla Fabiana Nunes, Coelho, Dieska Quintiliano, Tavares, Jordânia Lumênia, da Cruz, Luciana Falcão, Kanda, Márcia Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109738/
https://www.ncbi.nlm.nih.gov/pubmed/25031058
http://dx.doi.org/10.1016/j.bjhh.2014.03.008
_version_ 1782327905411399680
author Barbosa, Maria Helena
da Silva, Karla Fabiana Nunes
Coelho, Dieska Quintiliano
Tavares, Jordânia Lumênia
da Cruz, Luciana Falcão
Kanda, Márcia Helena
author_facet Barbosa, Maria Helena
da Silva, Karla Fabiana Nunes
Coelho, Dieska Quintiliano
Tavares, Jordânia Lumênia
da Cruz, Luciana Falcão
Kanda, Márcia Helena
author_sort Barbosa, Maria Helena
collection PubMed
description OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was performed with a quantitative approach by analyzing 316 donation files from February 2010 to December 2011. The IBM SPSS Statistics program was used for data processing and analysis. The chi-square test was used to verify whether there was an association between factors related to the procedure and the donor, and the adverse events that occurred. RESULTS: The mean age of platelet donors was 40 years old (standard deviation = 8.9), with the prevalent age group being between 40 and 49 years old; the prevalent blood type was O positive (53.8%), the mean duration of the procedure was 73 min and the mean amount of anticoagulant used was 360 mL. The association between procedure duration and the volume of anticoagulant was inverse and statistically significant; the longer the procedure and the greater the volume of anticoagulant used, the less adverse reactions occurred. CONCLUSION: The low incidence of adverse events indicates that the procedure is well tolerated by donors. Obtaining data regarding the incidence of adverse events is a way of promoting a dynamic review of medical and nursing teams to improve the safety and comfort of the donor.
format Online
Article
Text
id pubmed-4109738
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-41097382014-07-25 Risk factors associated with the occurrence of adverse events in plateletpheresis donation Barbosa, Maria Helena da Silva, Karla Fabiana Nunes Coelho, Dieska Quintiliano Tavares, Jordânia Lumênia da Cruz, Luciana Falcão Kanda, Márcia Helena Rev Bras Hematol Hemoter Original Article OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was performed with a quantitative approach by analyzing 316 donation files from February 2010 to December 2011. The IBM SPSS Statistics program was used for data processing and analysis. The chi-square test was used to verify whether there was an association between factors related to the procedure and the donor, and the adverse events that occurred. RESULTS: The mean age of platelet donors was 40 years old (standard deviation = 8.9), with the prevalent age group being between 40 and 49 years old; the prevalent blood type was O positive (53.8%), the mean duration of the procedure was 73 min and the mean amount of anticoagulant used was 360 mL. The association between procedure duration and the volume of anticoagulant was inverse and statistically significant; the longer the procedure and the greater the volume of anticoagulant used, the less adverse reactions occurred. CONCLUSION: The low incidence of adverse events indicates that the procedure is well tolerated by donors. Obtaining data regarding the incidence of adverse events is a way of promoting a dynamic review of medical and nursing teams to improve the safety and comfort of the donor. Sociedade Brasileira de Hematologia e Hemoterapia 2014 2014-04-03 /pmc/articles/PMC4109738/ /pubmed/25031058 http://dx.doi.org/10.1016/j.bjhh.2014.03.008 Text en © 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Original Article
Barbosa, Maria Helena
da Silva, Karla Fabiana Nunes
Coelho, Dieska Quintiliano
Tavares, Jordânia Lumênia
da Cruz, Luciana Falcão
Kanda, Márcia Helena
Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title_full Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title_fullStr Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title_full_unstemmed Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title_short Risk factors associated with the occurrence of adverse events in plateletpheresis donation
title_sort risk factors associated with the occurrence of adverse events in plateletpheresis donation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109738/
https://www.ncbi.nlm.nih.gov/pubmed/25031058
http://dx.doi.org/10.1016/j.bjhh.2014.03.008
work_keys_str_mv AT barbosamariahelena riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation
AT dasilvakarlafabiananunes riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation
AT coelhodieskaquintiliano riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation
AT tavaresjordanialumenia riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation
AT dacruzlucianafalcao riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation
AT kandamarciahelena riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation